Overview

A Study of MDT-10013 in the Treatment of Acute Postoperative Pain Following Bunionectomy

Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of MDT-10013 in men and women 18 to 80 years of age who are undergoing bunionectomy. The primary objective is to determine the analgesic efficacy of MDT-10013 compared with standard of care in the treatment of acute postoperative pain after subjects undergo bunionectomy.
Phase:
Phase 2
Details
Lead Sponsor:
Medtronic Spinal and Biologics